Latest Breaking News On - Polypid ltd - Page 1 : vimarsana.com

PolyPid Ltd. Schedules Shareholder Meeting

has released an update. PolyPid Ltd. has announced its Annual and Extraordinary General Meeting of Shareholders, scheduled for July ...

PolyPid Enhances Share Option Plan to Motivate Staff

PolyPid Ltd. (NASDAQ:PYPD) Q1 2024 Earnings Call Transcript

PolyPid (NASDAQ:PYPD) Given Buy Rating at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of PolyPid (NASDAQ:PYPD – Free Report) in a research note published on Wednesday, Benzinga reports. They currently have a $14.00 target price on the stock. HC Wainwright also issued estimates for PolyPid’s Q1 2025 earnings at ($0.81) EPS, Q2 2025 earnings at ($0.77) EPS, Q3 2025 earnings […]

PolyPid (NASDAQ:PYPD) Earns "Buy" Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of PolyPid (NASDAQ:PYPD – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. The brokerage currently has a $14.00 target price on the stock. HC Wainwright also issued estimates for PolyPid’s Q1 2025 earnings at ($0.81) EPS, Q2 2025 earnings at ($0.77) EPS, […]

Analyzing Co-Diagnostics (NASDAQ:CODX) and PolyPid (NASDAQ:PYPD)

PolyPid (NASDAQ:PYPD) vs. LeMaitre Vascular (NASDAQ:LMAT) Head-To-Head Comparison

PolyPid (NASDAQ:PYPD – Get Free Report) and LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, profitability, risk and earnings. Earnings and Valuation This table compares PolyPid and […]

Reviewing LeMaitre Vascular (NASDAQ:LMAT) & PolyPid (NASDAQ:PYPD)

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) and PolyPid (NASDAQ:PYPD – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Valuation & Earnings This table compares LeMaitre Vascular […]

Financial Review: LeMaitre Vascular (NASDAQ:LMAT) versus PolyPid (NASDAQ:PYPD)

PolyPid (NASDAQ:PYPD – Get Free Report) and LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends. Analyst Ratings This is a summary of recent […]

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

More Than 100 Patients Enrolled in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Infections Unblinded Interim Analysis to be Conducted Once Approximately 400 Patients Complete Their 30-Day Follow-up; Top-line Results Expected in Second Half of 2024 New Preclinical Data Showed OncoPLEX Injected Intratumorally Reduced Tumor Volume and Improved Survival in New Animal Models Recent Successful $16 Million Financing Extends Company’s Cash Runway